MoonLake Immunotherapeutics - Class A — Dividend History & Yield (NASDAQ:MLTX) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Dividends per share —————— — Dividend yield % —————— — Payout ratio % —————— —

新闻

MoonLake: Downgrade To Buy As Sonelokimab Still Has A BLA Shot On Goal (NASDAQ:MLTX)

MoonLake Immunotherapeutics (MLTX) Analyst/Investor Day - Slideshow (NASDAQ:MLTX) 2026-02-23

MoonLake Immunotherapeutics (MLTX) Analyst/Investor Day Transcript

MoonLake股价因axSpA试验数据积极而飙升

MoonLake stock surges on positive axSpA trial data

InvestingPro公允价值预测后MoonLake股价飙升63%

MoonLake stock surges 63% after InvestingPro Fair Value call

MoonLake公布轴性脊柱关节炎2期临床试验阳性数据

MoonLake reports positive phase 2 axial spondyloarthritis data

ImageneBio appoints Dr. Porter-Brown as Chief Medical Officer

BTIG重申Moonlake Immunotherapeutics股票买入评级，静待数据公布

BTIG reiterates Buy rating on Moonlake Immunotherapeutics stock ahead of data